Dr Simon Hirst

Simon is Sygnature Discovery’s Founder and Chief Executive Officer. Starting as a medicinal chemist at AstraZeneca, Simon has built a 30 year long career spanning the full spectrum of drug discovery programs and business leadership. After founding Sygnature Discovery in 2004, Simon has shaped the company into a world-class partner for tailored drug discovery services, fostering a strong scientific culture and driving significant growth. Under his leadership, Sygnature has expanded globally, secured strategic acquisitions, and established a reputation for scientific excellence and innovation, while maintaining the people-first approach that continues to drive its success. 

Simon holds a BSc (Hons.) in Chemistry and a PhD in Synthetic Organic Chemistry from the University of Nottingham and undertook key post-doctoral research at the University of Pittsburgh. He has broad-ranging research experience from AstraZeneca and OSI Pharmaceuticals, as well Combi Pure Ltd. where he served as Managing Director and Director of Chemistry. 

Latest News

View All

Sygnature Discovery boosts growth of its In…

Sygnature Discovery Appoints New Chief Commercial Officer…

Sygnature Discovery appoints Rick Davies to spearhead…

Sygnature Discovery has Chosen Elsevier as New…